Abstract

Genome-wide association studies (GWAS) involve testing genetic variants across the genomes of many individuals to identify genotype-phenotype associations. GWAS have revolutionized the field of complex disease genetics over the past decade, providing numerous compelling associations for human complex traits and diseases. Despite clear successes in identifying novel disease susceptibility genes and biological pathways and in translating these findings into clinical care, GWAS have not been without controversy. Prominent criticisms include concerns that GWAS will eventually implicate the entire genome in disease predisposition and that most association signals reflect variants and genes with no direct biological relevance to disease. In this Review, we comprehensively assess the benefits and limitations of GWAS in human populations and discuss the relevance of performing more GWAS.

Keywords

Genome-wide association studyBiologyGenetic associationDiseaseGeneticsComputational biologyGenomeSingle-nucleotide polymorphismGenotypeGeneMedicinePathology

MeSH Terms

AnimalsGenetic Association StudiesGenetic Predisposition to DiseaseGenetic VariationGenomeGenome-Wide Association StudyGenotypeHumansPhenotype

Affiliated Institutions

Related Publications

Publication Info

Year
2019
Type
review
Volume
20
Issue
8
Pages
467-484
Citations
2028
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

2028
OpenAlex
46
Influential

Cite This

Vivian Tam, Nikunj Patel, Michelle Turcotte et al. (2019). Benefits and limitations of genome-wide association studies. Nature Reviews Genetics , 20 (8) , 467-484. https://doi.org/10.1038/s41576-019-0127-1

Identifiers

DOI
10.1038/s41576-019-0127-1
PMID
31068683

Data Quality

Data completeness: 81%